News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Jason Westin: CAR T-Cell Therapy Offers Best Chance for Long-Term Remission in Advanced Cancers
Jason Westin/LinkedIn
May 31, 2025, 14:16

Jason Westin: CAR T-Cell Therapy Offers Best Chance for Long-Term Remission in Advanced Cancers

Jason Westin, Professor, Director of Lymphoma Clinical Research and Section Chief of Aggressive Lymphoma at MD Anderson Cancer Centre, shared a post on LinkedIn:

“CAR T-cell therapy offers the best chance for long-term remission — and perhaps cure — for patients with some advanced cancers. But here’s the reality: only 2 in 10 eligible patients in the U.S. receive it. That must change.
Today, CAR T Vision launches with an ambitious but achievable goal: double access to CAR T-cell therapy by 2030. We’re building a movement to make our vision real — for patients, caregivers, clinicians, and advocates.
It will take all of us working together.
Read the new roadmap report and see how you can be part of the coalition.”

You Can Also Read CAR T Cell Therapy for Cancer Treatment by OncoDaily.

CAR T Cell Therapy

cancer CAR T-cell therapy Jason Westin OncoDaily Oncology
Special Coverage
Opinion
May 31, 2025, 14:16
Jason Westin: CAR T-Cell Therapy Offers Best Chance for Long-Term Remission in Advanced Cancers
Science
May 31, 2025, 14:02
Paolo Tarantino: The MSK Retrospective Experience With ADC Sequencing for MBC
Blog
May 31, 2025, 13:44
Sarah Sammons Highlights 77% Response Rate with Carboplatin, Bevacizumab, and PD-1 Inhibitors in TNBC Brain Metastases
Blog
May 31, 2025, 13:38
Local Evidence Post #18: Childhood Cancer Treatment Abandonment in Gondar, Ethiopia - CANCaRe Africa
Blog
May 31, 2025, 13:32
Petros Grivas: Congrats to All Conquer Cancer, the ASCO Foundation Young Investigator Awards Recipients
Blog
May 31, 2025, 13:12
Paolo Tarantino: Join a Comprehensive Symposium on the Present and Future of ADCs in Breast Oncology
Blog
May 31, 2025, 13:10
Lobular Breast Cancer IRL Advocates for Standardised Breast Density Reporting in Ireland
Science
May 31, 2025, 12:57
Sameer Rastogi Shared Early Results from SORASTOP Trial on Discontinuing Sorafenib in Desmoid Tumors
Blog
May 31, 2025, 12:52
Fumiko Ladd Chino: Seeing Friends, Colleagues, and Collaborators Who Live in Other Places is The Best Part of ASCO
Career
May 31, 2025, 12:32
Margarita Dionysiou Awarded St. Baldrick’s Fellowship for Leukemia Research - Johns Hopkins Kimmel Cancer Center
Blog
May 31, 2025, 12:22
Giselle Sholler: The Best Part about ANR is Connecting with Friends and Colleagues, New and Old
Insight
May 31, 2025, 12:13
E. Shyam P. Reddy: Researchers Identified a New Biomarker to Predict Outcomes in KRAS G12C-Mutated NSCLC